William J. Bommer clinical interests focus on sonography (thoracic esophageal and gastric imaging) and intraluminal echocardiography. Bommer is evaluating risk factors for preclinical disease, morbidity and mortality in patients aged 65 or older. His diagnostic cancer modalities include a mouse tumor model with human tumors, using echo contrast and super paramagnetic agents to target tumors. Other projects involve computer simulation of blood-flow models in finite difference analysis, restenosis prevention with time-release oligonucleotide site-specific delivery, bronchial airway circulation, and new contrast agents.
M.D., State University of New York School of Medicine, Buffalo, New York, 1972
B.A., Cornell University, Ithaca, New York, 1968
State University of New York, Buffalo, New York, 1975
Martinez VA Hospital , Martinez, California, 1977
University of California, Davis Medical Center, Sacramento, California, 1977
American Board of Internal Medicine, 1975
American Board of Internal Medicine, Cardiovascular Disease, 1977
American College of Cardiology
American Heart Association
American Society of Echocardiography
Select Recent Publications
Herrmann HC, Kar S, Siegel R, Fail P, Loghin C, Lim S, Hahn R, Rogers JH, Bommer W, Wang A, Berke A, Lerakis S, Kramer P, Wong SC, Foster E, Glower D, Feldman T on behalf of the EVEREST investigators. Effect of percutaneous mitral valve repair with the MitraClip area and gradient. EuroIntervention 2009; 4:437-442.
Mann JFE, Schmieder RE, McQueen M, Dyal, L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Matsarinne K, Oto A, Parkhomenko A, Piegas LS, Svendsen TL, Teo KK, Yusuf S, on behalf of the ONTARGET Investigators. (969 collaborators including WJ Bommer) Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 372(9638): 547-553.
The ONTARGET Investigators. (969 collaborators including WJ Bommer) Telmisartan, ramipril or both in patients at high risk for vascular events. New England Journal of Medicine 2008; 358(15): 1547-1559.
WJ Bommer. Use of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker therapy to reduce cardiovascular events in high-risk patients: part 2. Preventive Cardiology 2008; 11: 215-222.
Bommer WJ. use of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy to reduce cardiovascular events in high-risk patients: Part 1. Preventive Cardiology 2008; 11(3): 148-154.
Lewis WR, Arena FJ Galloway MT, Bommer WJ. Acute myocardial infarction associated with dobutamine stress echocardiography. Journal of the American Society of Echocardiography 1997;10(5):576-578
Ezekowitz MD, Hossack K, Mehta J, Thadani U, Weidler D, Kostuk W, Awan N, Grossman, Bommer WJ. Amlodipine in chronic stable angina: Results of a multicenter double-blind crossover trial. American Heart Journal 1995;129: 527-535
Gardin JM, Siscovick D, Anton-Culver H, Lynch JC, Smith VE, Klopfenstein HS, Bommer WJ, Fried L, O'Leary D, Manolio TA. Sex, Age and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly: The Cardiovascular Health Study 1995;91(6):1739-1748
Bommer WJ, Follette D, Pollock M, Arena F. Bognar M, Berkoff H. Tamponade in patients undergoing cardiac surgery: A clinical- echocardiographic diagnosis. American Heart Journal 1995;130: 1216-1223.
Cushing GL, Fitzgerald PJ, Bommer WJ Andrews MW, Cronan MS, Martinez-Torres GG, Jang Y-T, Belef WM, Prindiville TP. Intraluminal ultrasonography during ERCP with high-frequency ultrasound catheters. Gastrointestinal Endoscopy 1993;39(3):432-435